Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2009
08/12/2009EP2086967A2 Inhibitors of hepatitis c virus
08/12/2009EP1089988B1 Fluorophenyl resin compounds
08/12/2009CN101506210A 2-phenoxy pyrimidinone analogues
08/12/2009CN101503413A Preparation of 5,6-dihydro-6-methieno [2,3-b] thiopyran-2-sulfonic acid amide-4-keto
08/12/2009CN101503412A Preparation of 5,6- dihydro-4-hydroxy-(S)-6- methylthieno [2,3-b] thiopyran
08/12/2009CN101503398A Novel sulfide or sulfone containing dianhydride, and preparation and use thereof
08/11/2009US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine
08/06/2009WO2009096080A1 Piperidine derivative
08/06/2009WO2009095394A1 Diazepanes as histamine h3 receptor antagonists
08/06/2009WO2009095253A1 6-halo-pyrazolo[1, 5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mglur) modulators
08/06/2009CA2713293A1 Piperidine derivative
08/05/2009EP2084164A2 Improved process for preparing clopidogrel
08/05/2009EP2010544B1 Process for preparing dorzolamide
08/05/2009EP1805144A4 Heterocyclical chromophore architectures
08/05/2009EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection
08/05/2009CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors
08/05/2009CN101500562A Thieno[3,2-c]pyridine-7-carboxylic acid derivatives
08/05/2009CN100522970C Stereoselective method for the production of clopidogrel
08/04/2009US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay
08/04/2009US7569580 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid
08/04/2009US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
07/2009
07/30/2009WO2009094123A1 Protein kinase inhibitors and use thereof
07/30/2009WO2009093013A1 Fused thiophene derivatives as mek inhibitors
07/30/2009WO2009093009A1 Fused tricyclic thiophene derivatives as mek inhibitors
07/30/2009WO2009093008A1 Thieno-pyridine derivatives as mek inhibitors
07/30/2009WO2009092278A1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
07/30/2009WO2009066326A3 Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
07/30/2009WO2009062044A3 Processes for the preparation of prasugrel, and its salts and polymorphs
07/30/2009WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
07/30/2009WO2009050242A3 Heterocycle-substituted piperazino-dihydrothienopyrimidines
07/30/2009US20090192178 mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS
07/30/2009US20090192176 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
07/30/2009US20090192144 Imidazo Compounds
07/30/2009CA2711629A1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
07/30/2009CA2709806A1 Protein kinase inhibitors and use thereof
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
07/29/2009EP1786807B1 Heterocyclic antiviral compounds
07/29/2009EP1771177A4 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
07/29/2009EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
07/29/2009EP1678166B1 Protein kinase inhibitors
07/29/2009CN101495487A Substituted benzodithiophenes and benzodiselenophenes
07/28/2009US7566721 Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
07/23/2009WO2009091374A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors
07/23/2009WO2009090866A1 Process for production of thiophene derivative
07/23/2009WO2009001214A3 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
07/23/2009WO2008103351A3 Heterocyclic aspartyl protease inhibitors
07/23/2009WO2008060597A8 Compounds useful as protein kinase inhibitors
07/23/2009US20090186887 Novel pyrimidothienoindazoles
07/23/2009US20090184313 Materials for organic electroluminescent devices
07/22/2009EP2079736A1 Substituted triazoles useful as axl inhibitors
07/22/2009EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives
07/22/2009CN101490059A Porphyrinogen derivatives useful as explosives detection markers
07/22/2009CN101490058A Antiviral agents
07/22/2009CN100516068C Plavix raceme resolution method
07/21/2009US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
07/16/2009US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases
07/16/2009US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/15/2009EP2078721A2 Thieno-pyrimidime compounds having fungicidal activity
07/15/2009EP2078025A2 Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof
07/15/2009EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/15/2009EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems
07/15/2009EP1805150A4 Heterocyclical chromophore architectures
07/15/2009CN101481380A Thiofuran pyridazine compound, preparation thereof, pharmaceutical composition and uses thereof
07/15/2009CN100513408C Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
07/14/2009US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
07/14/2009US7560549 Sulfonyloxy derivatives
07/14/2009US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders
07/14/2009CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof
07/10/2009WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/10/2009WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/10/2009CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/10/2009CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/09/2009WO2009086028A2 Carbazole-containing materials in phosphorescent light emitting diodes
07/09/2009WO2009085256A1 Anti-hiv compounds
07/09/2009WO2009084693A1 Antitumor agent
07/09/2009WO2009054814A8 Functionalized poly (3,4-alkylenebridgedthiophene) (pabt)
07/09/2009US20090176825 Prolyl hydroxylase inhibitors
07/09/2009US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
07/09/2009US20090176279 Bioreactive agents
07/09/2009DE19962661B4 Verfahren zur Herstellung von Hexahydro-2-oxo-1H-thieno[3,4-d]-imidazol-4-pentansäure Process for the preparation of hexahydro-2-oxo-1H-thieno [3,4-d] imidazole-4-pentanoic acid
07/09/2009CA2710740A1 Antitumor agent
07/08/2009EP2077590A1 Field-effect transistor
07/08/2009EP2077122A1 Therapeutic agents for irritable bowel syndrome
07/08/2009EP2076519A2 Novel dithiolopyrrolones and their therapeutical applications
07/08/2009EP1073647B1 12,13-cyclopropane epothilone derivatives
07/08/2009CN101479278A Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives
07/08/2009CN101479277A Pyrimidine derivatives as PI3K inhibitors
07/08/2009CN101475577A Clopidogrel sulphate double salt compound and preparation thereof
07/08/2009CN100510091C Overcoming DAPA aminotransferase bottlenecks in biotin vitamers
07/08/2009CN100509818C Multipurpose linker compounds and ligands and process for producing the same
07/08/2009CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections
07/08/2009CN100509761C Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557112 Aromatic-ring-fused pyrimidine derivative
07/07/2009US7557111 {1-[7-(4-bromo-2,6-dimethyl-phenyl)-2-methyl-thieno[3,2-d]pyrimidin-4-yl]-piperidin-4-yl}-methanol; depression, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastral diseases, drug dependence, epilepsy, cerebral, inflammation, immunity, sleep, IBS, alopecia
07/07/2009US7557101 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives
07/07/2009US7557059 epoxidation of isopulegol with hydrogen peroxide in presence of a oxidation catalyst system containing sodium tungstate ( NaWO4.2H2O), sodium hydrogen sulfate, phosphoric or boric acid and methyltrioctylammonium chloride to produce isopulegol epoxide; high catalytic activity; chemical intermediate
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/02/2009WO2009080469A1 Process for the preparation of clopidogrel bisulphate form i
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 214